Virtu Financial LLC Karyopharm Therapeutics Inc. Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.68 - $1.31 $6,804 - $13,109	10,007 New	10,007 $9,000
Q2 2022 Aug 09, 2022	BUY	$4.15 - $8.37 $54,518 - $109,956	13,137 New	13,137 $59,000
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $81,119 - $193,774	-18,229 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$8.11 - $11.11 $233,770 - $320,245	-28,825 Reduced 61.26%	18,229 $188,000
Q1 2021 May 19, 2021	SELL	$9.85 - $17.69 $29,865 - $53,636	-3,032 Reduced 6.05%	47,054 $495,000
Q4 2020 Feb 24, 2021	BUY	$14.15 - $17.19 $708,716 - $860,978	50,086 New	50,086 $775,000
Q4 2019 Feb 04, 2020	SELL	$9.23 - $19.67 $94,764 - $201,951	-10,267 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$5.66 - $11.85 $58,111 - $121,663	10,267 New	10,267 $99,000
Q4 2018 Jan 16, 2019	SELL	$8.2 - $16.95 $94,021 - $194,348	-11,466 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$17.03 - $21.18 $225,545 - $280,507	-13,244 Reduced 53.6%	11,466 $195,000
Q1 2018 May 14, 2018	BUY	$9.92 - $17.25 $245,123 - $426,247	24,710 New	24,710 $332,000
Q4 2017 Feb 09, 2018	SELL	$9.15 - $11.99 $167,380 - $219,333	-18,293 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$8.15 - $11.16 $149,087 - $204,149	18,293	18,293 $0

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.